MPWT
DYN icon

MassMutual Private Wealth & Trust’s Dyne Therapeutics DYN Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.4K Hold
243
– – ﹤0.01% 1649
2026
Q1 		$4.41K Hold
243
– – ﹤0.01% 1730
2025
Q4 		$4.75K Hold
243
– – ﹤0.01% 1692
2025
Q3 		$3.07K Hold
243
– – ﹤0.01% 1860
2025
Q2 		$2.31K Buy
+243
New +$2.67K ﹤0.01% 1910

Other funds holding DYN

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return
DWM
Darwin Wealth Management Tampa, Florida $365M AUM 22.69% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

MassMutual Private Wealth & Trust's DYN Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Dyne Therapeutics (DYN) position steady in Q2 2026 at 243 shares worth $5.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1649.

MassMutual Private Wealth & Trust first reported a position in DYN in Q2 2025 and has held it in 5 quarters since. 43 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • MassMutual Private Wealth & Trust held 243 shares of Dyne Therapeutics worth $5.4K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Dyne Therapeutics share count unchanged in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1649 holding.
  • MassMutual Private Wealth & Trust first reported a position in Dyne Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 43 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.